XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Investments, cost $ 1,851,977 [1] $ 1,792,304 [2]
Deferred financing costs, net $ 7,014 $ 7,628
Common stock par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 56,373,217 56,958,440
Common stock, shares outstanding (in shares) [3] 56,262,964 56,958,440
Non-controlled, non-affiliated investments    
Investments, cost $ 1,629,044 $ 1,617,126
Non-controlled, affiliated investments    
Investments, cost 138,586 91,476
Controlled investments    
Investments, cost $ 84,347 $ 83,702
[1] Represents amortized cost for debt securities and cost for equity investments.
[2] Represents amortized cost for debt securities and cost for equity investments.
[3] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share reflect the reverse stock split on a retroactive basis.